Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Antimicrobial Agents and Chemotherapy|March 28, 1998
Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faeciumM J Rybak, D M Cappelletty, T Moldovan, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Effect of norfloxacin on theophylline pharmacokinetics at steady stateS K Bowles, Z Popovski, M J Rybak, et al.
Clinical Pharmacology and Therapeutics|April 1, 1994
Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairmentS C Boike, M A Pue, M I Freed, et al.
The Journal of Infectious Diseases|September 1, 1993
Prospective evaluation of red man syndrome in patients receiving vancomycinT L O'Sullivan, M J Ruffing, K C Lamp, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1990
Vancomycin pharmacokinetics in burn patients and intravenous drug abusersM J Rybak, L M Albrecht, J R Berman, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1994
Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection modelS L Kang, M J Rybak, B J McGrath, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1990
Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditisG W Kaatz, S M Seo, S L Barriere, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1989
Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditisG W Kaatz, S M Seo, S L Barriere, et al.
Pharmacotherapy|September 22, 2000
Once-daily aminoglycoside in the treatment of Enterococcus faecalis endocarditis: case report and reviewV H Tam, P S Mckinnon, D P Levine, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1991
Development of resistance to fleroxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditisG W Kaatz, S M Seo, S L Barriere, et al.
Pageof 14